Long-term diabetes leads to macrovascular and microvascular complication. In diabetic retinopathy (DR), persistent hyperglycemia causes permanent loss of retinal pericytes and aberrant proliferation of microvascular endothelial cells (EC). Adipose tissue-derived stromal cells (ASC) may serve to functionally replace retinal pericytes and normalize retinal microvasculature during disease progression. We hypothesized that Notch signaling in ASC underlies regulation and stabilization of dysfunctional retinal microvascular networks such as in DR. ASC prominently and constitutively expressed NOTCH2. Genetic knockdown of NOTCH2 in ASC (SH-NOTCH2) disturbed the formation of vascular networks of human umbilical cord vein endothelial cells both on monolayers of ASC and in organotypical three-dimensional cocultures with ASC. On ASC SH-NOTCH2, cell surface platelet-derived growth factor receptor beta was downregulated which disrupted their migration toward the chemoattractant platelet-derived growth factor beta subunits (PDGF-BB) as well as to conditioned media from EC and bovine retinal EC. This chemoattractant is secreted by pro-angiogenic EC in newly formed microvascular networks to attract pericytes. Intravitreal injected ASC SH-NOTCH2 in oxygen-induced retinopathy mouse eyes did not engraft in the preexisting retinal microvasculature. However, the in vivo pro-angiogenic capacity of ASC SH-NOTCH2 did not differ from controls. In this respect, multifocal electroretinography displayed similar b-wave amplitudes in the avascular zones when either wild type ASC or SH-NOTCH2 ASC were injected. In conclusion, our results indicate that NOTCH2 is essential to support in vitro vasculogenesis via juxtacrine interactions. In contrast, ongoing in vivo angiogenesis is influenced by paracrine signaling of ASC, irrespective of Notch signaling. STEM CELLS 2017; 00:000-000
INTRODUCTION
Patients affected by diabetes are at risk for developing microvascular complications due to dysregulated glucose metabolism. One of these complications, namely diabetic retinopathy (DR), weakens the capillaries in the eyes leading to blindness [1] . At the cellular level, hyperglycemia (HG) compromises the juxtacrine interactions between pericytes and microvascular endothelial cells (EC) which constitute the retinal capillary network [2] . This is followed by a hypoxia-driven pro-angiogenic response that causes an increase in retinal dysfunctional capillaries that lack pericytic coverage. In normal physiology pericytes wrap around EC, which results in juxtacrine and paracrine cross-communication between the cells that establishes the endothelial barrier and serves to maintain endothelial function [3, 4] . Retinal capillaries have the highest pericytes density in the body; each EC is supported by one pericyte which emphasizes the importance of pericytes in the retina. Migration, differentiation, and stabilization of EC all highly depend on interactions with pericytes.
Stem cell therapy has been exploited for replacement of compromised or lost tissue cells for several decades. Among these therapeutically relevant cells mesenchymal stem cells (MSC), such as adipose tissue-derived stromal/stem cells (ASC) [5] , have a strong a potency to differentiate into smooth muscle cells and pericytes [6, 7] . Besides this constructive role, ASC are instructive in regenerative processes and secrete a host of mediators that favor the formation and maintenance of blood vessels, that is, vascular endothelial growth factor (VEGF), plateletderived growth factor (PDGF), angiopoetins-1 and 2 (Ang-1, Ang-2) [8] [9] [10] . Moreover, ASC promote remodeling of the extracellular matrix [11, 12] , which is essential during vasculogenesis. Less well-known is that ASC act in a juxtacrine manner, that is, engaging in cell-to-cell contact with target cells to influence their function. In vitro, ASC monolayers induce vascular(-like) network formation (VNF) of EC, thereby creating a relevant model for investigating the responsible juxtacrine mediators on ASC [13] . ASC cultured in vitro phenotypically resemble pericytes and can replace lost pericytes in rodent models of experimental DR [14] . Importantly, we recently showed that ASC are resilient to HG in VNF of EC, suggesting that ASC may be promising for early stage treatment of DR [15] .
An important family of proteins involved in vascular morphogenesis and maintenance is the Notch family [16] . Mammals express four Notch receptors (NOTCH1 to 4) and five membrane bound ligands (JAGGED 1-2 and Delta-like 1-3 and 4) . After binding to their ligands, Notch receptors are proteolytically activated by a complex of tumor necrosis factor-betaconverting enzyme (ACE) and gamma-secretase. This releases the Notch intracellular domain (NICD) which translocates into the nucleus and binds to C-promoter-binding factor (CBF-1/ RBPJk/Su[H]/Lag-1) and coactivator Mastermind-like (MAML) and activates the transcription of downstream genes in particular HEY and HES [17] [18] [19] . Furthermore, NICD has been shown to form complex with endothelial transcription factor (ERG) and b-catenin, mediating in turn Ang1-dependent delta-like 4 (Dll4)/Notch signaling in EC [20] . The role of Notch signaling in vascular stability is enhanced by supporting neighboring cells. For example, activation of smooth muscle genes in bona fide pericytes, requires interaction with EC by binding of cell surface NOTCH3 and JAGGED1 [21, 22] . Capillary branching, differentiation, and patterning processes in the retina depend on equilibrium between Notch ligands and receptors on adjacent cells. Indeed, JAGGED1 is a potent proangiogenic factor which antagonizes Dll4/Notch signaling on EC during sprouting angiogenesis. Pericyte recruitment and JAGGED1 expression results in NOTCH1 upregulation, suppression of tip cells' DLL4 and reduced stalk cells responsiveness to VEGF-A, ultimately leading to homeostasis of the capillaries bed [23, 24] . Besides, Notch signaling activation reduces the volume of age-related macular degeneration [25] . The latter study highlights the role of Notch signaling in maintaining the balance between proangiogenic genes such as VEGF Receptor 2 (VEGFR2), C-C chemokine receptor 3 (CCR3) and PDGF-BB and antiangiogenic genes such as VEGFR1 and UNC5B.
Much of the action of ASC is achieved by paracrine signaling, yet pericytes and EC also communicate via juxtacrine signaling. We argued that given the differences in sensitivity to HG between ASC and bona fide pericytes, juxtacrine signaling will differ too. The current study aims at understanding the role of Notch signaling in the pericytic function of ASC in vitro and, in a mouse model of pathological vasoproliferation.
MATERIALS AND METHODS

Primary Cell Cultures and Isolation
ASC were isolated from lipoaspirates as described previously [26] . Anonymously donated samples were obtained with informed consent as approved by the ethical board of the University Medical Center Groningen following the guidelines for "waste materials." Propagation of ASC was in dulbecco's modified eagle's medium (DMEM) (BioWhittaker, Walkersville, MD): 10% bovine serum albumin (BSA), 1% l-Glutamine, 1% Penicillin/Streptomycin (P/S); which was changed for EC medium (ECM, roswell park memorial institute (RPMI)-1640 (Lonza Biowhittaker Verviers, Belgium), 10% heat inactivated FBS (Thermo Scientific, Hemel Hempstead, U.K.), 100 U/ml penicillin, 100 mg/ml streptomycin (Invitrogen, Carlsbad, CA), 2 mM L-glutamine (Lonza Biowhittaker Verviers, Belgium), 5 U/ml heparin (Leo Pharma, The Netherlands), and 5 mg/ml of EC growth factor) prior to coculture experiments. Human umbilical cord vein endothelial cells (HUVEC) were obtained from Lonza (Breda, The Netherlands) and the Endothelial Cell Facility of University Medical Center Groningen, The Netherlands. ASC and HUVEC were seeded at 4 3 10 4 /cm 2 . HUVEC were cultured on gelatin-coated tissue culture polystyrene. Bovine retinal endothelial cells (BREC) were isolated from retinas of bovine eyes purchased at the local slaughter house [27] . Upon receipt the eyes were briefly immersed in 70% ethanol for sterilization purposes. The retinas were harvested from the eyes (approximately 80 eyes per isolation) and washed in DMEM. Subsequently, the retinas were minced in small pieces and incubated with an enzyme cocktail: collagenase type 4 (500 mg/ml, Thermo Fisher Scientific, MA), DNase (200 mg/ml, Roche Diagnostic, Mannheim, Germany) and, pronase E (200 mg/ml, Roche Diagnostic, Mannheim, Germany) at 378C for 30 minutes. The digested retinas were filtered through a 53 mm mesh nylon filter and the cell homogenate seeded on gelatin coated plates in DMEM (BioWhittaker, Walkersville, MD): 10% FBS, 1% l-Glutamine, 1% Penicillin/Streptomycin (P/S). Cells' medium was refreshed every 3 days. ASC and HUVEC were used between passage 3 and 5. BREC passaged twice were used for downstream applications.
Gene Transcript Analysis
The gene expression profiles of Notch members were analyzed in ASC and HUVEC or BREC. Total RNA was extracted using Trizol Reagent (Life technologies, Carlsbad, CA) according to the manufacturer's protocol. Afterward, 1 mg of total RNA was reverse transcribed using the First Strand cDNA synthesis kit (Fermentas UAB, Vilnius, Lithuania) according to the manufacturer's instructions. The cDNA equivalent of 5 ng RNA was used for amplification in 384-well microtiter plates in a TaqMAN ABI7900HT cycler (Applied Biosystem, Foster City, CA) in a final reaction volume of 10 ml containing 5 ml SybrGreen universal polymerase chain reaction (PCR) Master Mix (BioRad, Richmond, CA) and 6 mM primer mix (forward and reverse). Cycle threshold (C T ) values for individual reactions were determined using ABI Prism-SDS 2.2 data processing software (Applied Biosystem, Foster City, CA). The C T values were normalized to GAPDH as a reference gene using the DC T method, normalizing for the expression of the reference gene and related to the control treatment. All cDNA samples were amplified in duplicate. Primer sequences for quantitative realtime reverse transcriptase-PCR (RT-qPCR) are listed in Table 1 .
Lentivirus Transduction
For lentiviral transductions to obtain the NOTCH2 knockdown, HEK cells were transfected using Endofectin-Lenti (Gene Copoeia, Rockville, MD, EFL-1001-01) with the following plasmids: pLKO.1-SH-NOTCH2 (Ge-healthcare bio-science, SE, Sweden) or pLKO.1-SCR, pVSV-G (envelope plasmid) and pCMVDR8.91 (gag-pol second generation packaging plasmid). A combination of five constructs was tested to improve the chance of downregulation. For NOTCH2, two constructs were proven to efficiently knock down NOTCH2 by eightfold at protein level. Virus collection was started the day after transfection. ASC (50% confluent) were transduced in DMEM, 10% FBS, supernatant containing viruses were added for two consecutive days. The first transduction was facilitated with 4 mg/ ml polybrene. Transduced cells were allowed to proliferate for another 3 days and were then selected with 2 mg/ml puromycin for at least 7 days. Transduction efficiency for NOTCH2 (reduced detectable protein by Western blotting analyses) was confirmed for all NOTCH2 knockdown cultures used in the experiments.
Vessel Network Formation Two Dimensions and Three Dimensions
ASC were plated on 15 mm Termanox coverslips (NUNC, Rochester, NY) at 1 3 10 4 /cm 2 in DMEM, 10% FBS for 24 hours. Next, medium was replaced with ECM for 5 days. HUVEC were seeded on top of ASC monolayers or on gelatin-coated coverslips at 1 3 10 4 /cm 2 in ECM and cultured for 5 days, after which vascular network formation was assessed. Threedimensional (3D) cocultures were achieved by embedding ASC and HUVEC (3 3 10 5 cells of each cell population) in 100 ll of matrigel (Corning, growth factor reduced, New York, U.S.) accommodated in a 3D printed scaffold (the scaffold was printed with a commercially available 3D printer; Reprap Prusa i3, Anet 3D, China; biodegradable material, polylactic acid, was used to print the scaffolds). Cells were grown for 9 days. HUVEC tubular formation and interconnection were assessed at 24 hours, 27 hours, 6 days, and 9 days. Immunostaining was performed as following. Samples were fixed in 4% paraformaldehyde in PBS for 20 minutes. Subsequently, cells were permeabilized with 1% BSA and 0.5% Triton-X100 in PBS at room temperature for 1 hour at 48C. After PBS washes, primary antibodies were incubated for 90 minutes: mouse-antihuman-CD31 (1:100, Dako, Glostrup, Denmark), rabbit-antihuman-NOTCH2 (Cell Signaling, Danvers, MA, 4530S). Samples were washed with PBS and incubated with the fluoresceinconjugated-donkey-anti-mouse-IgG (for CD31, PECAM-1) (1:500, Jackson Immunoresearch, U.K.) and to fluoresceinconjugated-goat-anti-rabbit IgG (for NOTCH2) (1:500, Jackson Immunoresearch, U.K.) in PBS containing 4 0 ,6-diamidino-2-phenylindole (DAPI). For colocalization staining in both two dimensions (2D) and 3D, ASC were CM-DiI-labeled (Thermo Fisher Scientific, Vybrant CM-DiI red Molecular Probes, Sanbio, Uden, The Netherlands), whereas HUVEC were staining for CD31. 2D VNF images were acquired by automated microscope TissueFAXS. Confocal microscope (SP8) was used to acquire z-stack images at 363. Post-processing for imaging was achieved using ImageJ free software [28] . 3D scaffolds were designed with SketchUp 2016 software. 3D VNF were reconstructed by imageJ 3D viewer plugin.
Immunoblotting
Cells were lysed in radioimmunoprecipitation assay buffer (RIPA buffer) (Thermo Fisher Scientific, Wiltham, MA), freshly supplemented with proteinase inhibitor cocktail and phosphatase inhibitor cocktails-2 and 3 (all from Sigma-Aldrich, St. Louis, MO). A total of 10 mg of protein per sample was loaded in each lane. Electrophoresis was performed in 10% polyacrylamide gels, followed by electrotransfer onto nitrocellulose membranes (Corning with semidry Transblot Turbo system (Bio-Rad). Membranes were blocked with Odyssey Blocking 
Terlizzi, Kolibabka, Burgess et al. Blots were then incubated with primary antibodies at 48C, overnight, and after washing with TBS, with secondary antibodies at room temperature for 1 hour. The membranes were washed three times with TBS with 0.1% Tween in between incubations and additionally with TBS before the scanning. Visualization of bound secondary antibodies was done with an Odyssey scanner (Li-COR Biosciences, Lincoln, NE) and digital images were captured. These were analyzed with Odyssey software (Li-COR Biosciences, Lincoln, NE), and densitometry was performed with TotalLab 120 software (Nonlinear Dynamics, Newcastle, U.K.). Images depicted in figures were processed in Adobe Photoshop and Illustrator, and if necessary, brightness of a whole image was adjusted in linear fashion for display purposes only (Adobe Systems Incorporated, San Jose, CA).
The following antibodies were used: Rabbit NOTCH2 (1:1,000, Cell Signaling, Danvers, MA, 4530S), Rabbit plateletderived growth factor receptor beta (PDGFRB) (1:250, Santa Cruz Biotechnology, Dallas, TX, sc-432), Mouse monoclonal GAPDH (1:1,000, Abcam, Cambridge, U.K., ab9485 or ab9484), anti-rabbit IgG IRDye-680LT (1:10,000, Li-COR Biosciences, Lincoln, NE, 92668021).
Migration Assay
Migration toward chemoattractant PDGF-BB (Recombinant human PDGF-BB, Peprotech, Inc., NJ), as well as to conditioned media of HUVEC and BREC was measured using a 48-well micro chemotaxis chamber with 8 mm pore size filters (Neuro probe, MD). A concentration of 20 ng/ml PDGF-BB proved optimal for migration and was used in further experiments. HUVEC and BREC were cultured in RPMI. Twenty-four hours later, medium was collected and filtered with a 20 mm filter (Corning, New York). The lower chamber contained RPMI supplemented with PDGF-BB, HUVEC and BREC conditioned medium, 8 3 10 3 cultured ASC, ASC SH-SCR [Scramble] and ASC SH-NOTCH2 were placed in the upper chamber. After incubation at 378C for 4 hours, migrated cells were fixed and stained with DAPI (Sigma, MO). Nuclei were counted in representative high power fields (12 chemotaxis chambers were quantified per condition, n 5 3 independent experiments) visualized with 340 objective magnification per sample.
Adhesion Assays
Single cell suspensions of ASC were seeded on confluent monolayers of HUVEC and monitored respectively for 8 hours (adhesion) and 36 hours (adhesion and proliferation). CM-DiI labeled ASC (Thermo Fisher Scientific, Vybrant CM-DiI Molecular Probes, Sanbio, Uden, The Netherlands) were used to discriminate ASC from HUVEC. At the end of the incubation, the cocultures were gently washed and fixed with 4% paraformaldehyde in PBS for 20 minutes. Nuclei were stained with DAPI. Stained nuclei and adhered red-labeled ASC were counted using an automated microscope TissueFAXS (TissueGnostics, Vienna, Austria).
Proliferation Assay
ASC (WT, SH-SCR, and SH-NOTCH2) were cultured in RPMI medium until confluency. Twenty-four hours after replacing fresh RPMI, medium was collected and filtered with a 20 mm filter (Corning, New York). HUVEC were seeded at 1 3 10 4 cells/cm 2 and allowed to attach for 2 hours before conditioned medium was added. After 3 days with ASC conditioned medium treatment, HUVEC were stained with a marker for proliferative cells (Anti-Ki67 antibody ab15580, 1:250, Abcam). Four field of views from four replicates per condition were quantified. ImageJ software was used to split colors. The images displaying Ki67 staining were transformed to 8-bit. To each image a threshold was applied. The pixels' area of Ki67 positive nuclei was quantified (n 5 3 independent experiments).
Animals and Oxygen-Induced Retinopathy Model
All animal experiments in this study were approved by the Institutional Animal Care and Use Committee (Regierungspr€ asidium Karlsruhe, Germany) and were performed according to guidelines of the statement of animal experimentation issued by the Association for Research in Vision and Ophthalmology (ARVO). C57Bl/6J mice were housed in groups in cages with free access to standard chow and water under 12 hours light and 12 hours dark rhythm. To study the influence of ASC on hyperoxic vasoregression and subsequent hypoxia-driven angiogenesis, newborn mice, female, and male were used to assess the migration and engraftment of ASC that were administered intravitreally. Mice at postnatal day 7 were exposed to 75% oxygen atmosphere for 5 days with their nursing mother, and then returned to room air (an 20% oxygen) at postnatal day 12. Directly after return to room air, randomly selected mice were intravitreally injected with either 0.5 ml of PBS containing 7 3 10 3 ASC (WT, SH-SCR, and SH-NOTCH2) or 0.5 ml PBS alone as control (Hamilton, Microliter Syringes). At P19, mice were under deep anesthesia for ERG analysis and for quantification of neovascularization, subsequently mice eyes were enucleated. After collection, eyes were either fixed in 4% buffered formalin or snap frozen and stored at 808C for later analysis. Whole mount retinas from P19 animals were permeabilized by treatment with 1% BSA and 0.5% Triton-X100 in PBS at room temperature for 1 hour. Overnight staining was with FITC-or TRITC-labeled isolectin-B4 (Sigma, 1:50) at 48C. After PBS washes, retinas were flatmounted in 50% glycerol and subsequently stained for microvasculature with Lectin-FITC (1/70, Sigma-Aldrich, Saint Louis, MO). Retinal capillaries and CMDiI-labeled ASC (red) were acquired with a fluorescence microscope (Leica BMR, Bensheim, Germany). Alternatively, confocal laser scanning microscopy was used (Leica TCS SP2 Confocal Microscope, Leica, Wetzlar, Germany) to assess (co-)localization of Lectin-TRITC-stained microvasculature and CMDiI-labeled ASC.
Multifocal Electroretinogram
Multifocal electroretinography was performed as previously described [29] . The mice were placed in front of the scanning laser ophthalmoscope device (RETImap, Roland Consult, Brandenburg, Germany), with a drift tube linac (DTL) electrode placed at the cornea. Subcutaneous silver needle electrodes were positioned at the neck of the mice serving as reference and ground electrodes. A 90 dpt (dioptrie) contact lens (Volk Optical, Inc., Mentor, OH) mounted over viscous 2% Methocel gel (OmniVision GmbH, Puchheim, Germany) was placed on the eyes of the mice. An array of 19 equally sized hexagons 
Statistical Analysis
All the data are presented as a mean with SD and were analyzed using GraphPad Prism 5 (GraphPad Software, Inc.). Statistical significance was determined using either one-way analysis of variance (ANOVA) with Bonferroni post hoc or Student's t test analysis depending on the experimental conditions. Values of p < .05 were considered statistically significant.
RESULTS
Assessment of Notch Components Expression by ASC
The Notch family comprises five ligands and four receptors in mammals. We characterized their basal gene expression in ASC (Fig. 1A) , BREC and HUVEC (Fig. 1B, 1C) . The expression of JAG1, JAG2, DLL1, DLL3, and DLL4 was detected in C T values not greater than 0.1 in ASC. In contrast, gene expression of the Notch receptors varied in ASC. NOTCH2 had the highest expression (C T value 0.251 6 0.09 normalized to GAPDH), followed by NOTCH1 (0.173 6 0.006), and NOTCH3 (0.117 6 0.003) while NOTCH4 had either very low expression levels or was not detectable depending on the ASC donor pool that was assessed.
The expression levels of JAG1, JAG2, DLL1, DLL4 ligands and NOTCH2, NOTCH3, and NOTCH4 receptors were all similar in HUVEC when compared with one another. Expression of DLL3 was not detectable, while NOTCH1 had the highest expression (0.248 6 0.033). In contrast, in BREC, expression of JAG1 was highest (0.247 6 0.043) compared to JAG2 (0.068 6 0.004). DLL1 expression was not detectable, while expression of DLL3 and DLL4 was similar to JAG2. NOTCH2 expression by ASC was confirmed at the protein level (Fig.  1D) . Besides, NOTCH2 protein was not expressed in HUVEC (Fig. 1D) . Immunohistochemistry on ASC and HUVEC confirmed NOTCH2 in ASC and NOTCH2 absence in HUVEC, respectively (Fig. 1E, 1F) .
The maintenance of ASC in normoglycemic (5 mM glucose) or hyperglycemic medium (25 mM glucose) from isolation onward, did not influence the expression of JAG1, nor NOTCH1-4 (Supporting Information Fig. S1 ), while expression of NOTCH2 was again higher than expression of the other members. Therefore, our investigations focused on NOTCH2.
NOTCH2 Downregulation Inhibits ASC's Capacity to Sustain Vessel Network Formation in 2D and 3D
The role of Notch signaling in controlling the sprouting of nascent vessels during angiogenesis is well characterized [30] . The pattern of Notch receptors and ligands expression on EC and pericytes is a regulated mechanism that controls new vessel development and homeostasis. NOTCH2 receptor expression on ASC may represent a possible mediator of ASC pericytic features. In order to test this hypothesis, we A short hairpin against NOTCH2 was lentiviral transduced in ASC to reduce its expression. The 85% of control ASC showed surface expression of NOTCH2 ( Fig. 2A) , while in ASC-SH-NOTCH2, 44% of cells had no detectable surface expression and the remainder had a significantly reduced surface expression of NOTCH2 (Fig. 2B) . NOTCH2 downregulation in ASC SH-NOTCH2 is further confirmed at protein level (Fig. 2C) .
Confluent monolayers of ASC wild type (ASC WT) and ASC transduced with a scrambled control (ASC SH-SCR) supported vascular network formation (VNF) by HUVEC (Fig. 2D, 2E ), corroborating our previous data [31] . Thus, the lentiviral transduction by itself did not affect VNF. HUVEC formed an interconnected branched network on the ASC monolayer which remained stable for at least 14 days. In contrast, monolayers of ASC reduced NOTCH2 surface expression (SH-NOTCH2) did not support VNF by HUVEC (Fig. 2F) . HUVEC that had precipitated by gravity on the ASC SH-NOTCH2 monolayer at best formed small clusters rather than tubular networks. However, lack of contact caused death of most seeded HUVEC (not shown). Confocal laser scanning microscopy revealed that the ASC adhered to and wrapped around the tubular structures formed by the HUVEC (Fig. 2G) . By focusing on the focal plane in which the HUVEC were located (Fig. 2H) , the defined tubular structure of the HUVEC identified through positive staining for PECAM-1 (red) could be seen surrounded by the ASC. By using reconstructed Z-stacks from transversal optical sections, the tubes were confirmed to harbor a lumen (Fig.  2I) . ASC in the vicinity of the HUVEC tubular structures, had intranuclear expression of NOTCH2, indicating that NOTCH2 was activated in these cells (Fig. 2J) . Nuclear translocation and localization of NOTCH2 is showed in Figure 2K . NOTCH2 was not detected in ASC SH-NOTCH2 monolayers (Fig. 2L) .
VNF is a valuable tool to assess vasculogenesis in vitro. However, this assay is limited in its nature as it is not truly reflective of the 3D environment cells experience in vivo. To address this limitation the influence of ASC on vasculogenesis, this process was investigated in a 3D printed scaffold microenvironment. The scaffold was used as a biodegradable container which allowed the matrigel to be held in place. ASC WT, SH-SCR, or SH-NOTCH2 were seeded and cocultured with HUVEC in matrigel supported by a 3D printed poly-lactic acid scaffold and followed for nine days (Fig. 3) . Within this time, ASC WT and ASC-SH SCR supported HUVEC to form an interconnected branching network. In contrast and similar to their performance in 2D, ASC SH-NOTCH2 did not support the formation of networks by co-seeded HUVEC (Fig. 3A) . Importantly, HUVEC alone did not sprout or form networks when embedded in matrigel at either a lower or high seeding density (Fig. 3B , right panel lower density and left panel higher density, respectively), confirming the important role of ASC in inducing the vasculogenic process. 3D image reconstruction of the VNF showed the CD31 (PECAM-1) positive HUVEC (green) Figure 4 . NOTCH2 is required for migration of ASC and their adhesion to endothelial cells, whereas endothelial cell proliferation is not affected. Medium containing PDGF-BB, HUVEC secretome, and BREC secretome was collected. ASC were cultured with standard medium and a neuroprobe system was used to measure ASC migration toward conditioned medium (A) ASC (WT, SH-SCR, and SH-NOTCH2) migration toward PDGF-BB as well as conditioned medium derived from BREC and HUVEC (B) Adhesion of ASC (WT, SH-SCR, and SHNOTCH2) on endothelial cells monolayer after 8 hours. (C): ASC (WT, SH-SCR, and SH-NOTCH2) conditioned medium was collected. Proliferation of endothelial cells treated with ASC conditioned medium was detected by Ki67 staining. ImageJ software was used to split colors. The images displaying Ki67 staining were transformed to 8-bit. To each image, a threshold was applied. The pixels' area of Ki67 positive nucleus were quantified (n 5 3 independent experiments). *, p .05, **, p .01, ***, p .001, unpaired t test and one-way ANOVA. Abbreviations: ANOVA, analysis of variance; ASC, adipose tissuederived stromal cells; BREC, Bovine retinal endothelial cells; HUVEC, human umbilical cord vein endothelial cells. 
PDGFRB, Migration and Adhesion Are Reduced in ASC SH-NOTCH2
To further examine the role of NOTCH2 in the ASC pericyticlike phenotype, their migratory capacity was investigated. Conditioned media from cultured HUVEC and BREC were used as chemoattractant. In addition, PDGF-BB, known to be an EC-secreted chemoattractant for pericytes, was used as a positive control. Wild type ASC and ASC SH-SCR migrated toward PDGF-BB in a similar fashion and also migrated similarly toward conditioned media of HUVEC or BREC (Fig. 4A) . In contrast, the migration of ASC SH-NOTCH2 was four-to fivefold lower toward PDGF-BB or conditioned media of HUVEC or BREC, compared to either control media (p .01, p .001, Fig. 4A ). In addition to the reduced responsiveness to chemoattractant of ASC SH-NOTCH2, their adhesion to HUVEC was also reduced (Fig. 4B) . The adhesion of ASC SH-NOTCH2 was approximately 30% lower than ASC WT and ASC SH-SCR (p .5; p .01, Fig. 4B ). Yet, knockdown of NOTCH2 did not influence other paracrine signaling by ASC: the proliferation (Ki67) of HUVEC was similar in conditioned media from control ASC and ASC SH-NOTCH2 (Fig. 4C) .
Because ASC SH-NOTCH2 had reduced migration toward EC-secreted chemoattractants and PDGF-BB, the expression of the receptor for PDGF (PDGFRB) was determined in ASC. Expression of PDGFRB was reduced sixfold (p .001, Fig. 5A ) in ASC SH-NOTCH2 compared to ASC WT. At the protein level, expression of PDGFRB by ASC SH-NOTCH2 was also reduced when compared to ASC WT or ASC SH-SCR controls (p .5, Fig. 5B, protein quantification Fig. 5C ).
ASC SH-NOTCH2 Do Not Acquire Pericytic Position in the Oxygen-Induced Retinopathy Retinal Microvasculature, but Maintain Paracrine ProRegenerative Capacity
In order to verify the findings obtained in vitro, ASC (WT, SH-SCR, and SH-NOTCH2) were injected in eyes of mice with oxygen-induced retinopathy (OIR). In this mouse model, pups are exposed to hyperoxia while the retinal vasculature is still developing. The subsequent return of pups at room air (an 20% oxygen) prompts excessive pathological angiogenesis [32] . Control ASC (WT and SH-SCR) and ASC SH-NOTCH2 were injected intravitreally at P7 immediately after 5 days of hyperoxia. Avascular areas in whole mount retinas were quantified at P19. Animals which had not received any ASC injection had large avascular areas in the central retina (Fig. 6A) . The administration of ASC WT, the scrambled control (ASC-SCR), and SHNOTCH2 largely restored the avascular areas (untreated animals avascular areas: 50,000 lm 2 ; ASC treated animals avascular areas: 10,000 lm 2 ). It appeared that the lentiviral integration by itself reduced the capacity to fully revascularize the central retina, because a complete central retinal microvasculature reconstitution was not observed (Fig. 6B-6D ). To further assess the functional status of retinal cell layers after ASC-induced revascularization, mfERG was performed and awaves (photoreceptor function) and b-waves (inner retinal function) were measured in avascular, vascular, and neovascular areas. With regard to avascular areas, a-waves measured in ASC WT, ASC SH-SCR, and ASC SH-NOTCH2 showed an increase in amplitude when compared to untreated eyes (p .01, Supporting Information Fig. S2A ). Subsequently, bwave amplitudes measured in the avascular areas showed significant increment when ASC WT were injected in the eyes and compared to ASC untreated animals (p .5, Supporting  Information Fig. S2B ). In contrast, ASC SH-SCR and ASC SH- NOTCH2 showed no difference among the groups. There were no differences detected in the a-wave and b-wave amplitudes measured in the vascular and neovacular zones across the groups (Supporting Information Fig. S2C-S2F) .
Imaging analyses performed on P19 mice retinas showed that control ASC (Supporting Information Fig. S3 , red) were homogeneously distributed around the microvasculature (green) in the retina. Control ASC (WT) had adhered to typical pericytic positions on the retinal capillaries, that is, on branching points and around capillaries (arrow heads, Supporting Information Fig.  S3) . Similarly, ASC SH-SCR controls also adhered at pericytic positions. In contrast, intravitreally administered ASC SH-NOTCH2 did not reach the retinal microvasculature, but formed intravitreal aggregates (Supporting Information Fig. S3 ).
DISCUSSION
This study demonstrates that Notch signaling is fundamental for ASC pericytic interaction and therapeutic function in the context of pathological retinal vasoproliferation. Specifically, NOTCH2 is essential for in vitro vascularization and subsequent stabilization. In addition, the expression of the Notch receptors and JAGGED1 ligand were refractory to HG. Both in vitro and in vivo, NOTCH2 promotes expression of PDGFRB on ASC which proved crucial for the EC-driven chemoattraction of ASC. Finally, NOTCH2 does not affect the pro-angiogenic paracrine function of ASC because in vivo, both ASC WT and ASC SH-NOTCH2 showed reconstitution of capillary beds. However, ASC with reduced NOTCH2 expression appeared to have lost their migratory capacities when introduced in an ischemic and neo-vascularized retinal microenvironment.
To date, few studies have investigated the molecular mechanisms that orchestrate ASC and their interaction with the retinal microvasculature [33, 34] . In contrast, the role of Notch signaling in angiogenesis is well-established [30] . Benedito et al. [35] concluded that Notch signaling modulates VEGFR2 and VEGFR3 in different manners in retinal EC. A specific Notch receptor was not identified in this study, however, Figure 6 . ASC SH-NOTCH2 partially recovered avascular area in the retina. Five days old C57BL/6 mice were exposed to 75% of oxygen for 5 days and then returned to room air (an 20% oxygen). ASC (WT, SH-SCR, and SH-NOTCH2) (7 3 10 3 cells/0.5 ll) were injected at day 7. Retina whole mounts were prepared on day 19 
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the overall Notch activity was ablated by gamma secretase inhibitor. They reported that VEGFR3 activation depends on both the Notch and VEGFR2-VEGF axis to promote angiogenesis on nascent vessels. Notch signaling alone was not sufficient to induce VEGFR2 activation. The latter suggests that more upstream regulators might be involved in cell-to-matrix interaction. In the current study, we show that genetic disruption of NOTCH2 in ASC prevents "docking" of EC to ASC and vice versa in vitro. Interestingly, in a 3D coculture system, NOTCH2 proved essential to promote vasculogenic behavior of HUVEC. The knockdown of NOTCH2 completely abrogated network formation by HUVEC.
It is well-known that endothelial-secreted PDGF-BB serves as a request for mural cell support during vasculogenesis and angiogenesis [36] . Our results show that NOTCH2 regulates the expression of PDGFRB on ASC, which is a prime chemotactic receptor of mural cells, that is, pericytes [37] . The retina has a specialized form of the blood brain barrier and the inhibition of PDGFRB signaling in developing murine retinas disrupted transendothelial barriers and caused vascular leakage [38] , very similar to blood-retina barrier (BRB) changes in DR. This is likely due to the lack of sufficient support by pericytes. Our experiments demonstrate the importance of NOTCH2 expression in the regulation of PDGFRB and as a consequence in the regulation of vasculogenesis and angiogenesis. The migration of ASC toward PDGF-BB but also to secreted factors from HUVEC and more importantly from retinal EC (BREC) depended on NOTCH2 signaling. Similarly, the ASC engraft required NOTCH2 expression and signaling. In fact, we observed ASC expressing NOTCH2 in the nucleus in the vicinity of the vasculature. The juxtacrine interaction between ASC and EC depended on NOTCH2 signaling, yet the paracrine influence of ASC on EC was not. On one hand, we showed that the proliferation of EC in vitro was not affected by conditioned medium of ASC SH-NOTCH2. On the other hand, in vivo, the restoration of avascular areas in OIR retinas, was virtually similar between controls and ASC SH-NOTCH2-injected animal eyes. However, the latter did not engraft in the retinal vasculature. The engraftment of ASC WT and accompanied vascular restoration corroborates findings of others [39] .
Initial a-waves, which are predominantly rod driven in rodents, were higher in amplitude in avascular areas when both ASC WT and ASC SH-NOTCH2 were injected compared with untreated animals. In contrast, there were no differences in the a-wave amplitude in neovascular and vascular areas. These data are in agreement with findings of others [40, 41] , which showed that human bone marrow MSC preferentially migrate toward sites of injury in the retina. The choice of the OIR mouse model was important from the perspective of cell engraftment. In this model the retinal vasculature is still in development [32] , conferring a more accessible microenvironment for exogenous cells' homing. Notably, the ischemiainduced retinal neovascularization in this model is not caused by HG. However, retinal ischemia, pre-retinal neovascularization and retinal gliosis, are all reproducible characteristic of DR applicable to the OIR mouse model [42] . In fact, we demonstrated that ASC SH-NOTCH2, retained the therapeutic capacities without physically interacting with inner layers of the retina microvasculature. Whether the latter finding is driven by PDGFRB downregulation or another mechanism is currently unknown. Moreover, positive b-wave generated by ON-bipolar cells showed significantly improved amplitude upon ASC injection. Specifically, avascular areas measured upon ASC WT or ASC SH-NOTCH2 injection, displayed the same order of improvement in b-wave compared with untreated animals. This finding indicates that ASC SH-NOTCH2 secretome influenced the retinal microenvironment. This event might be attributed to either a direct downregulation of NOTCH2 in ASC, or a combinatorial effect of NOTCH2 downregulation and the impaired retinal microenvironment apply on ASC. Being more in favor of the latter, these observations suggest a role for both paracrine and juxtacrine signaling for the proper functioning of ASC in the retinal microenvironment. A summary of the process investigated in this study showed the importance of retinal chemoattractant to recruit ASC. Alternatively, ASC juxtacrine signals are equally fundamental as the paracrine signals in order to adapt to the retinal microenvironment.
CONCLUSION
Our results demonstrate the intrinsic capacity of ASC to promote, orchestrate, and sustain endothelial cell networks through an evolutionary conserved mechanism, namely Notch signaling. Moreover, the 3D coculture assay showed temporal dynamics of ASC driven vasculogenesis in vitro. Importantly, Notch components on ASC are not affected by HG. The latter combined with in vivo experiments, suggested that ASC are promising for therapeutic intervention in DR but more research is needed to understand the ASC response to signals from the pathological extracellular microenvironment into the diabetic retina. Finally, we propose that molecular intervention is fundamental to improve and understand the ASC regenerative armamentarium.
